Our research showed that N-glycosylation of ACTRIIB not only enhanced its membrane localization but also promoted the proliferation of tumor cells, consistent with findings in other types of tumors where ACTRIIB has been shown to promote tumor growth. Here, ACVR2B is linked to neoplasm.